In rhabdoid tumors the situation might be somewhat different as biallelic mutation of the chromatin remodeling factor SMARCB1 deregulates multiple tumor pathways (SHH, polycomb mediated pathways and Rb mediated pathways) (Figure 6). This evidence concerns the gene SHH and rhabdoid tumor.